G6PD Antibody / Pentose Phosphate Pathway Enzyme Antibody (R31611)

G6PD Antibody Human Liver Cancer IHC. Immunohistochemical staining of FFPE human liver cancer tissue using G6PD Antibody at 2 ug/ml with HRP/DAB detection following heat-induced epitope retrieval in pH8 EDTA buffer. Moderate to strong cytoplasmic staining is observed throughout the tumor cells, consistent with the expected localization of the G6PD enzyme in the cytosol. This staining pattern demonstrates the utility of G6PD Antibody, a Pentose Phosphate Pathway Enzyme Antibody, for investigating G6PD expression, cellular metabolism and oxidative stress in human liver cancer.

G6PD Antibody Human A549 IF. Immunofluorescent staining of A549 human lung carcinoma cells using G6PD Antibody (green) following enzyme-mediated antigen retrieval and DAPI nuclear counterstaining (blue). G6PD exhibits predominantly cytoplasmic staining, consistent with its role as a cytosolic enzyme in the pentose phosphate pathway responsible for NADPH production and redox homeostasis. This result demonstrates the utility of G6PD Antibody, a Pentose Phosphate Pathway Enzyme Antibody, for investigating G6PD localization, cellular metabolism and oxidative stress responses in cultured human cells.

G6PD Antibody Human Cancer Cell WB. Western blot analysis of G6PD Antibody using lysates from lane 1: human HeLa cells, lane 2: human MCF-7 cells and lane 3: human A549 cells. A single prominent band is detected at approximately 59 kDa in all three cell lines, consistent with the predicted molecular weight of endogenous G6PD. These results demonstrate reliable detection of G6PD in human cancer cells and support the use of G6PD Antibody, a Pentose Phosphate Pathway Enzyme Antibody, for studies of cellular metabolism, NADPH production and oxidative stress.

G6PD Antibody Mouse and Rat WB. Western blot analysis of G6PD Antibody using lysates from lane 1: rat C6 cells and lane 2: mouse RAW264.7 cells. A specific band is detected at approximately 59 kDa in both samples, consistent with the predicted molecular weight of endogenous G6PD. These results demonstrate cross-species recognition of G6PD and support the use of G6PD Antibody, a Pentose Phosphate Pathway Enzyme Antibody, for studies of cellular metabolism, NADPH production and redox regulation in rodent models.

G6PD Antibody Human MCF-7 IP. Immunoprecipitation of endogenous G6PD from MCF-7 human breast cancer cell lysate using G6PD Antibody, followed by Western blot detection with the same antibody. Lane 1: MCF-7 input lysate, lane 2: rabbit IgG negative control immunoprecipitation, and lane 3: G6PD immunoprecipitation. A specific band is detected at approximately 59 kDa in the input and G6PD immunoprecipitate, while no corresponding band is observed in the IgG control, demonstrating specific enrichment of endogenous G6PD. This result supports the use of G6PD Antibody, a Pentose Phosphate Pathway Enzyme Antibody, for immunoprecipitation and studies of G6PD-associated metabolic pathways.

G6PD Antibody Human MCF-7 FACS. Flow cytometry analysis of fixed and permeabilized MCF-7 human breast cancer cells stained with G6PD Antibody at 1 ug/10^6 cells, followed by a Fluoro488-conjugated secondary antibody. The blue histogram (G6PD) exhibits a clear rightward shift relative to the rabbit IgG isotype control (green) and unstained cells (red), demonstrating specific intracellular detection of endogenous G6PD. These results support the use of G6PD Antibody, a Pentose Phosphate Pathway Enzyme Antibody, for analyzing G6PD expression and cellular metabolic activity by flow cytometry.